PL358304A1 - Peptyd modulujący aktywność receptora trombopoetyny - Google Patents

Peptyd modulujący aktywność receptora trombopoetyny

Info

Publication number
PL358304A1
PL358304A1 PL01358304A PL35830401A PL358304A1 PL 358304 A1 PL358304 A1 PL 358304A1 PL 01358304 A PL01358304 A PL 01358304A PL 35830401 A PL35830401 A PL 35830401A PL 358304 A1 PL358304 A1 PL 358304A1
Authority
PL
Poland
Prior art keywords
receptor modulating
thrombopoietin receptor
modulating peptide
peptide
thrombopoietin
Prior art date
Application number
PL01358304A
Other languages
English (en)
Inventor
Tatjana Naranda
Lennart Olsson
Original Assignee
Pliva, Farmaceutska Industrija, Dionicko Drustvo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva, Farmaceutska Industrija, Dionicko Drustvo filed Critical Pliva, Farmaceutska Industrija, Dionicko Drustvo
Publication of PL358304A1 publication Critical patent/PL358304A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL01358304A 2000-04-25 2001-04-23 Peptyd modulujący aktywność receptora trombopoetyny PL358304A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00108075A EP1149906A1 (en) 2000-04-25 2000-04-25 Thrombopoietin receptor modulating peptide
PCT/EP2001/004553 WO2001080873A2 (en) 2000-04-25 2001-04-23 Thrombopoietin receptor modulating peptide

Publications (1)

Publication Number Publication Date
PL358304A1 true PL358304A1 (pl) 2004-08-09

Family

ID=8168467

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01358304A PL358304A1 (pl) 2000-04-25 2001-04-23 Peptyd modulujący aktywność receptora trombopoetyny

Country Status (24)

Country Link
US (1) US20030181659A1 (pl)
EP (2) EP1149906A1 (pl)
JP (1) JP2003530867A (pl)
KR (1) KR20030009450A (pl)
CN (1) CN1426467A (pl)
AR (1) AR030278A1 (pl)
AU (2) AU6736601A (pl)
BG (1) BG107214A (pl)
BR (1) BR0110383A (pl)
CA (1) CA2407167A1 (pl)
CZ (1) CZ20023517A3 (pl)
EA (1) EA006423B1 (pl)
EE (1) EE200200610A (pl)
GE (1) GEP20063763B (pl)
HU (1) HUP0300559A3 (pl)
IL (1) IL152204A0 (pl)
IS (1) IS6582A (pl)
MX (1) MXPA02010458A (pl)
NO (1) NO20025114L (pl)
PL (1) PL358304A1 (pl)
SK (1) SK15262002A3 (pl)
WO (1) WO2001080873A2 (pl)
YU (1) YU79202A (pl)
ZA (1) ZA200208662B (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002359362A1 (en) * 2001-11-07 2003-05-19 Millennium Pharmaceuticals, Inc. Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 or 58874
US7923431B2 (en) * 2001-12-21 2011-04-12 Ferrosan Medical Devices A/S Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
ES2781475T3 (es) * 2002-09-18 2020-09-02 Janssen Pharmaceuticals Inc Métodos para aumentar la producción de células madre hematopoyéticas y plaquetas
US7955288B2 (en) 2002-12-11 2011-06-07 Ferrosan Medical Devices A/S Gelatine-based materials as swabs
CN1820024B (zh) * 2003-05-12 2011-06-22 阿费麦克斯公司 新的聚(乙二醇)修饰的化合物及其用途
US7919118B2 (en) * 2003-05-12 2011-04-05 Affymax, Inc. Spacer moiety for poly (ethylene glycol) modified peptide based compounds
JP2005187435A (ja) * 2003-12-26 2005-07-14 Otsuka Chemical Co Ltd 血小板産生促進組成物
CA2554994C (en) 2004-01-30 2015-05-19 Ferrosan A/S Haemostatic sprays and compositions
KR20070046093A (ko) 2004-07-09 2007-05-02 훼로산 아크티에 셀스카브 히알루론산을 포함하는 지혈 조성물
WO2007088849A1 (ja) * 2006-01-31 2007-08-09 Mitsubishi Kagaku Iatron, Inc. 播種性血管内凝固症候群の病態把握方法
CA2716872C (en) 2008-02-29 2015-02-10 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
WO2012157586A1 (ja) * 2011-05-13 2012-11-22 国立大学法人東京大学 多核化巨核球細胞、及び血小板の製造方法
CN104159527B (zh) 2012-03-06 2017-04-12 弗罗桑医疗设备公司 包含止血糊剂的压力容器
RU2636240C2 (ru) 2012-06-12 2017-11-21 Ферросан Медикал Дивайсиз А/С Сухая гемостатическая композиция
JP6390873B2 (ja) 2013-06-21 2018-09-19 フェッローサン メディカル ディバイス エー／エス 減圧膨張させた乾燥組成物およびそれを保持するためのシリンジ
BR112016013322B1 (pt) 2013-12-11 2020-07-21 Ferrosan Medical Devices A/S métodos para preparação de uma composição seca e para reconstituir uma composição seca, composição seca, uso de uma composição seca, e, kit
BR112017007466B1 (pt) 2014-10-13 2021-03-02 Ferrosan Medical Devices A/S método para preparar uma composição seca, método para reconstituir a composição seca, pasta, composição seca, recipiente, kit homeostático, e, uso de uma composição seca
RU2705905C2 (ru) 2014-12-24 2019-11-12 Ферросан Медикал Дивайсиз А/С Шприц для удерживания и смешивания первого и второго веществ
CA2986981A1 (en) 2015-07-03 2017-01-12 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
EP4321182A3 (en) 2018-05-09 2024-05-29 Ferrosan Medical Devices A/S Method for preparing a haemostatic composition
WO2026005476A1 (ko) * 2024-06-26 2026-01-02 주식회사 넥스세라 혈소판 감소증 치료를 위한 재조합 단백질 및 이의 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5498599A (en) * 1994-01-21 1996-03-12 Amgen Inc. Methods for stimulating platelet production
AU6046696A (en) * 1995-06-07 1996-12-30 Glaxo Group Limited Peptides and compounds that bind to a receptor
US6342220B1 (en) * 1997-08-25 2002-01-29 Genentech, Inc. Agonist antibodies
EP1064015A2 (en) * 1998-02-24 2001-01-03 Receptron, Inc. Receptor derived peptides as modulators of receptor activity

Also Published As

Publication number Publication date
SK15262002A3 (sk) 2003-05-02
YU79202A (sh) 2006-01-16
IS6582A (is) 2002-10-14
EE200200610A (et) 2004-08-16
BG107214A (bg) 2003-11-28
EP1278849A2 (en) 2003-01-29
GEP20063763B (en) 2006-03-10
AR030278A1 (es) 2003-08-20
EA006423B1 (ru) 2005-12-29
BR0110383A (pt) 2003-01-21
US20030181659A1 (en) 2003-09-25
EA200201138A1 (ru) 2003-06-26
WO2001080873A3 (en) 2002-01-31
AU2001267366B2 (en) 2005-06-30
AU2001267366B9 (en) 2005-07-14
NO20025114L (no) 2002-12-18
IL152204A0 (en) 2003-05-29
CA2407167A1 (en) 2001-11-01
NO20025114D0 (no) 2002-10-24
HUP0300559A2 (hu) 2003-06-28
AU6736601A (en) 2001-11-07
WO2001080873A2 (en) 2001-11-01
HUP0300559A3 (en) 2005-09-28
CN1426467A (zh) 2003-06-25
MXPA02010458A (es) 2003-06-06
KR20030009450A (ko) 2003-01-29
JP2003530867A (ja) 2003-10-21
EP1149906A1 (en) 2001-10-31
CZ20023517A3 (cs) 2003-10-15
ZA200208662B (en) 2003-10-27

Similar Documents

Publication Publication Date Title
HUP0300559A3 (en) Thrombopoietin receptor modulating peptide
GB0014870D0 (en) Peptides
GB0029777D0 (en) Peptides
AU6268901A (en) Oligopeptides
GB0015761D0 (en) Polypeptide
GB0000474D0 (en) Receptor
GB0127017D0 (en) New polypeptide
AU1252102A (en) Receptor
GB0001825D0 (en) Peptides
GB0120704D0 (en) Polypeptide
HK1054406A (en) Thrombopoietin receptor modulating peptide
GB0124559D0 (en) New polypeptide
GB0007263D0 (en) Peptides
GB0027537D0 (en) New polypeptide
GB2388486B (en) Projection unit
GB0013239D0 (en) Polypeptide
EP1323731A4 (en) NEW PEPTIDES
GB0012199D0 (en) New polypeptide
GB0027989D0 (en) Modulator
GB0020946D0 (en) Modulator
GB0001826D0 (en) Peptides
GB0021475D0 (en) Anti-aniogenic peptides
GB0007264D0 (en) Peptides
GB0010327D0 (en) Peptides
AU1790P (en) Jabiru Glycine max

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)